Blockchain Registration Transaction Record

Calidi Biotherapeutics Names Dr. Guy Travis Clifton as Chief Medical Officer to Advance Clinical Development of CLD-201 Virotherapy

Calidi Biotherapeutics appoints Dr. Guy Travis Clifton as Chief Medical Officer to lead development of CLD-201 virotherapy for solid tumors, showcasing potential advancements in cancer treatment.

Calidi Biotherapeutics Names Dr. Guy Travis Clifton as Chief Medical Officer to Advance Clinical Development of CLD-201 Virotherapy

This news matters as it highlights the strategic appointment of an experienced oncologist to lead the development of innovative cancer therapies. The advancement of CLD-201 could potentially revolutionize treatment options for solid tumors, offering hope for improved patient outcomes and enhanced efficacy.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xa16599123bb4e6a093bde2f1094bbfaacb4cbc6cd373a37d04e3238dfa45d0f0
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintyogaTSUz-7d08955b7f6882adddf3aa2cf686c60b